Skip to content

Clinical study on the changes in TNFRSF9 and cytokine levels in patients with acute coronary syndrome and cardiac arrest

Clinical study on the changes in TNFRSF9 and cytokine levels in patients with acute coronary syndrome and cardiac arrest

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119908
Enrollment
Unknown
Registered
2026-03-05
Start date
2021-10-10
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome and Cardiac Arrest

Interventions

Case group:None
Control group:None

Sponsors

Yingshang Chengdong Hospital (formerly Yingshang First Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the Department of Cardiology of our institution during the study period who met the diagnostic criteria for acute coronary syndrome (UA/STEMI/NSTEMI) according to the Chinese Guidelines for the Diagnosis and Treatment of Acute Coronary Syndrome. 2. For patients with ACS complicated by CA, the causal relationship between CA and ACS must be confirmed (CA occurring within 24 hours after the onset of ACS symptoms). 3. Age between 18 and 75 years, regardless of sex. 4. Possessing basic communication ability and willing to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe hepatic or renal dysfunction (hepatic function: ALT/AST > 3 × upper limit of normal; renal function: eGFR < 30 mL/min/1.73 m²). 2. History of severe infection (e.g., pneumonia, sepsis) or use of immunosuppressive agents (e.g., glucocorticoids, cyclosporine) within 1 month prior to enrollment. 3. Presence of hematological diseases (e.g., leukemia, aplastic anemia) or malignancies. 4. Pregnant or lactating women. 5. Patients with psychiatric disorders or those unable to cooperate with data collection and follow-up. 6. Patients with incomplete clinical data (e.g., coronary angiography reports, medication records).

Design outcomes

Primary

MeasureTime frame
The correlation between the level of TNFRSF9 in the peripheral blood of ACS patients and the severity of coronary artery stenosis;

Secondary

MeasureTime frame
The differences in TNFRSF9 and cytokine levels between ACS patients with concurrent CA and those without concurrent CA;The differences in TNFRSF9 and cytokine levels between survivors and deceased patients 28 days after CA resuscitation;

Countries

China

Contacts

Public ContactYang Haibing

Yingshang Chengdong Hospital (formerly Yingshang First Hospital)

boeinglennox@outlook.com+86 188 5145 9797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026